Trials / Completed
CompletedNCT02063165
Healthy Oils for Women (HOW Study)
Healthy Oils for Women: Reducing Visceral Adipose Tissue in Women with Metabolic Syndrome (HOW Study)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- Female
- Age
- 50 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to understand the role of a dietary oil to alter chronic disease risk factors in women who are at risk for heart disease and/or diabetes. The investigator's previous study showed that safflower oil reduced trunk fat mass in women with diabetes. The investigators believe safflower oil can also attenuate criteria of metabolic syndrome through reduction in trunk fat mass.
Detailed description
The long-term goal is to develop effective and novel dietary and lifestyle strategies to reduce the progression of metabolic syndrome to chronic diseases such as coronary heart disease. The rationale for conducting this research study is that there are few effective strategies that target changes in body composition and metabolism as a means to attenuate metabolic syndrome. The investigators plan to test the central hypothesis and accomplish the overall objective of this research by pursuing the following three specific aims. Specific Aim 1: Quantify the extent that linoleic acid reduces trunk adipose mass in women with metabolic syndrome. Specific Aim 2: Measure changes in visceral adipose tissue Specific Aim 3: Determine the time-dependent effect of linoleic acid to increase adiponectin levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | High Linoleic Safflower Oil | 2 tsp per day (\~10g of oil) |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2014-02-14
- Last updated
- 2024-10-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02063165. Inclusion in this directory is not an endorsement.